Between 5 and 10 million people could lose Medicaid coverage in 2028 due to changes from the One Big Beautiful Bill Act, depending on the steps states take to mitigate

Deciding which AI tools to adopt isn’t about hype — it’s about evidence and real-world impact, according to Rebecca Mishuris, chief health information officer and vice president of digital at

Kailera Therapeutics isn’t the only company developing an obesity drug that hits multiple targets for weight loss, but the clinical-stage biotech believes its lead drug candidate can beat other medicines

A Rocket Pharmaceuticals gene therapy has landed a long-awaited FDA approval, bringing a new treatment option to patients with a certain inherited immunodeficiency so severe that many babies do not

Everlywell, an at-home lab testing company, is partnering with AI-powered gut microbiome company Jona to bring a gut microbiome test to consumers nationwide. Everlywell is a direct-to-consumer company selling tests

Health systems should use data to identify problems before buying AI tools, according to Arcadia CEO Michael Meucci. The market is flooded with vendors pitching AI solutions — but instead

For years, robotic bronchoscopy was confined mainly to elite academic centers and referral hospitals that possessed the budgets, staffing, and infrastructure required to support early-generation systems. That era is ending.

Millions of Americans are struggling to access physical and behavioral healthcare, and providers across the country are overworked, understaffed and face significant economic pressure. Nonetheless, they are expected to innovate

The Department of Justice filed an antitrust lawsuit against NewYork-Presbyterian Hospital this week, alleging the provider used restrictive payer contracts to block lower-cost plans. The agency claims the health system

UnitedHealthcare launched a generative AI companion on Thursday called Avery, which aims to improve care coordination for members. Avery can support members with a variety of issues like coverage and